Mayo Clinic Oncology Review 2016 July 23, 2016, in Minneapolis
This program provides an overview of the most recent advances in the treatment of various oncologic malignancies, based on abstracts presented at the June 2016 annual meeting of the American Society of Clinical Oncology.
Methylated DNA Markers and Whole Body Cancer Screening John B. Kisiel, M.D., discusses a study that identified sources of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors. Screening for cancer anywhere in the body with a noninvasive blood test or stool sample may be possible.